Vitamin E can significantly improve liver function in patients with non-alcoholic fatty liver diseases (NAFLD) including non-alcoholic steatohepatisis (NASH), a meta-analysis of five clinical trials.
The review, published in the journal Nutrition, found the vitamin improved serum biochemical parameters and hepatic clinical guidelines on NAFLD/NASH.
NAFLD is a team used to describe liver diseases involving hepatic
steatosis -or fatty change- without excessive alcohol intake and
includes a wide range of liver diseases from simple fatty change to
non-alcoholic steatohepatitis (NASH). NASH causes liver cirrhosis
-scarring of the liver and subsequent loss of function due to long-term
damage -and may develop into hepatocellular carcinoma, the most common
type of liver cancer.